Focal Interest
Focal Interest

Pharmaceutical Economics and Policy

External reference: https://openalex.org/T11792

  1. Goma medicine retailers share common professional features
    Qualitative study examining medicine retailers in Goma as an emerging professional group despite diverse backgrounds, revealing how they integrate commercial and healthcare logics to provide.
  2. Industry payments were linked to more brand-name MS prescribing
    Pharmaceutical payments to clinicians correlated with reduced generic prescribing for MS medications, increasing costs for patients and the healthcare system overall.
  3. Most favored nation drug pricing may lower industry research revenue
    Analysis of most favored nation drug pricing as policy mechanism to reduce international price disparities and effects on pharmaceutical research investment and innovation.
  4. Zuranolone was approved for postpartum depression, not major depressive disorder
    Analysis of zuranolone approval reveals how fast-track designations and reduced evidentiary thresholds in drug regulation may inadequately balance innovation with public health protection.
  5. Drug shortages create risks in obstetric care
    Clinical analysis of drug shortages in obstetric care addressing causation, prediction, and systematic response mechanisms for healthcare institutions.